NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 14 October 2008

New funds for Reaxa

Reaxa has completed a rights issue underwritten by its institutional investors, EV and YFM Private Equity. Reaxa will use the funds for sales and marketing expansion and for commercial scale production of its scavenger and EnCat catalyst ranges.
Reaxa

No comments: